Neldam, Steen <br/><br/>
Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.  [electronic resource] 

 -  Current medical research and opinion  Sep 2014 
 - 1715-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2014.924912  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antihypertensive Agents--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Benzoates--therapeutic use<br/>Clinical Trials, Phase III as Topic<br/>Drug Combinations<br/>Female<br/>Humans<br/>Hydrochlorothiazide--therapeutic use<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Randomized Controlled Trials as Topic<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Telmisartan<br/>Treatment Outcome